These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36788600)

  • 41. Development of the reproduction number from coronavirus SARS-CoV-2 case data in Germany and implications for political measures.
    Khailaie S; Mitra T; Bandyopadhyay A; Schips M; Mascheroni P; Vanella P; Lange B; Binder SC; Meyer-Hermann M
    BMC Med; 2021 Jan; 19(1):32. PubMed ID: 33504336
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Estimating the effect of mobility on SARS-CoV-2 transmission during the first and second wave of the COVID-19 epidemic, Switzerland, March to December 2020.
    Lison A; Persson J; Banholzer N; Feuerriegel S
    Euro Surveill; 2022 Mar; 27(10):. PubMed ID: 35272745
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Demographic and socio-economic factors, and healthcare resource indicators associated with the rapid spread of COVID-19 in Northern Italy: An ecological study.
    Buja A; Paganini M; Cocchio S; Scioni M; Rebba V; Baldo V
    PLoS One; 2020; 15(12):e0244535. PubMed ID: 33370383
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Substantial impact of mobility restrictions on reducing COVID-19 incidence in Italy in 2020.
    Vinceti M; Balboni E; Rothman KJ; Teggi S; Bellino S; Pezzotti P; Ferrari F; Orsini N; Filippini T
    J Travel Med; 2022 Sep; 29(6):. PubMed ID: 35876268
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Real-time estimation of the effective reproduction number of SARS-CoV-2 in Aotearoa New Zealand.
    Binny RN; Lustig A; Hendy SC; Maclaren OJ; Ridings KM; Vattiato G; Plank MJ
    PeerJ; 2022; 10():e14119. PubMed ID: 36275456
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of meteorological factors on SARS-CoV-2 infection incidence in Italy and Spain before the vaccination campaign. A multi-city time series study.
    Donzelli G; Biggeri A; Tobias A; Nottmeyer LN; Sera F
    Environ Res; 2022 Aug; 211():113134. PubMed ID: 35307374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.
    Charlton CL; Nguyen LT; Bailey A; Fenton J; Plitt SS; Marohn C; Lau C; Hinshaw D; Lutsiak C; Simmonds K; Kanji JN; Zelyas N; Lee N; Mengel M; Tipples G
    Microbiol Spectr; 2021 Sep; 9(1):e0029121. PubMed ID: 34406813
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study.
    Fabiani M; Puopolo M; Morciano C; Spuri M; Spila Alegiani S; Filia A; D'Ancona F; Del Manso M; Riccardo F; Tallon M; Proietti V; Sacco C; Massari M; Da Cas R; Mateo-Urdiales A; Siddu A; Battilomo S; Bella A; Palamara AT; Popoli P; Brusaferro S; Rezza G; Menniti Ippolito F; Pezzotti P;
    BMJ; 2022 Feb; 376():e069052. PubMed ID: 35144968
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study.
    Zhang J; Litvinova M; Wang W; Wang Y; Deng X; Chen X; Li M; Zheng W; Yi L; Chen X; Wu Q; Liang Y; Wang X; Yang J; Sun K; Longini IM; Halloran ME; Wu P; Cowling BJ; Merler S; Viboud C; Vespignani A; Ajelli M; Yu H
    Lancet Infect Dis; 2020 Jul; 20(7):793-802. PubMed ID: 32247326
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Socioeconomically Disadvantaged Neighborhoods Face Increased Persistence of SARS-CoV-2 Clusters.
    De Ridder D; Sandoval J; Vuilleumier N; Azman AS; Stringhini S; Kaiser L; Joost S; Guessous I
    Front Public Health; 2020; 8():626090. PubMed ID: 33614571
    [No Abstract]   [Full Text] [Related]  

  • 52. Evidence of pandemic fatigue associated with stricter tiered COVID-19 restrictions.
    Delussu F; Tizzoni M; Gauvin L
    PLOS Digit Health; 2022 May; 1(5):e0000035. PubMed ID: 36812519
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study.
    Laxminarayan R; B CM; G VT; Arjun Kumar KV; Wahl B; Lewnard JA
    Lancet Infect Dis; 2021 Dec; 21(12):1665-1676. PubMed ID: 34399090
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modelling and predicting the spatio-temporal spread of cOVID-19 in Italy.
    Giuliani D; Dickson MM; Espa G; Santi F
    BMC Infect Dis; 2020 Sep; 20(1):700. PubMed ID: 32967639
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transmission dynamics and control of two epidemic waves of SARS-CoV-2 in South Korea.
    Ryu S; Ali ST; Noh E; Kim D; Lau EHY; Cowling BJ
    BMC Infect Dis; 2021 May; 21(1):485. PubMed ID: 34039296
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dynamic Panel Data Modeling and Surveillance of COVID-19 in Metropolitan Areas in the United States: Longitudinal Trend Analysis.
    Oehmke TB; Post LA; Moss CB; Issa TZ; Boctor MJ; Welch SB; Oehmke JF
    J Med Internet Res; 2021 Feb; 23(2):e26081. PubMed ID: 33481757
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impacts of reopening strategies for COVID-19 epidemic: a modeling study in Piedmont region.
    Pernice S; Castagno P; Marcotulli L; Maule MM; Richiardi L; Moirano G; Sereno M; Cordero F; Beccuti M
    BMC Infect Dis; 2020 Oct; 20(1):798. PubMed ID: 33115434
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estimation and worldwide monitoring of the effective reproductive number of SARS-CoV-2.
    Huisman JS; Scire J; Angst DC; Li J; Neher RA; Maathuis MH; Bonhoeffer S; Stadler T
    Elife; 2022 Aug; 11():. PubMed ID: 35938911
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis.
    Rostami A; Sepidarkish M; Leeflang MMG; Riahi SM; Nourollahpour Shiadeh M; Esfandyari S; Mokdad AH; Hotez PJ; Gasser RB
    Clin Microbiol Infect; 2021 Mar; 27(3):331-340. PubMed ID: 33228974
    [TBL] [Abstract][Full Text] [Related]  

  • 60. COVID-19 Post-Exposure Evaluation (COPE) Study: Assessing the Role of Socio-Economic Factors in Household SARS-CoV-2 Transmission within Campania Region (Southern Italy).
    Gentile I; Iorio M; Zappulo E; Scotto R; Maraolo AE; Buonomo AR; Pinchera B; Muto G; Iervolino C; Villari R; Schiano Moriello N; Scirocco MM; Triassi M; Paternoster M; Russo V; Viceconte G; Federico Ii Covid-Team
    Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.